NCT04960072View on ClinicalTrials.gov

Study on TIL for the Treatment of r/r Gastrointestinal Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2021

Primary Completion Date

December 30, 2025

Study Completion Date

July 30, 2026

Conditions
Gastrointestinal Tumor
Interventions
BIOLOGICAL

Tumor Infiltrating Lymphocytes (TIL)

Adoptive transfer of 1x10\^9-5x10\^10 autologous TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

Unknown

RECRUITING

Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai 10th People's Hospital

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY